MPX International Corporation (MPXOF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 1, 2025
MPX International Revenue
MPX International had revenue of 2.02M CAD in the quarter ending March 31, 2022, a decrease of -7.55%. This brings the company's revenue in the last twelve months to 6.69M, up 14.35% year-over-year. In the fiscal year ending September 30, 2021, MPX International had annual revenue of 7.21M with 127.36% growth.
Revenue (ttm)
6.69M CAD
Revenue Growth
+14.35%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
144.00 USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2021 | 7.21M | 4.04M | 127.36% |
| Sep 30, 2020 | 3.17M | 1.58M | 99.27% |
| Sep 30, 2019 | 1.59M | 1.53M | 2,369.36% |
| Sep 30, 2018 | 64.45K | 55.73K | 638.69% |
| Mar 31, 2018 | 8.73K | - | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |